Abbott has delivered new, longer-term data from a clinical study of its dissolving stent for severe peripheral artery disease ...
today announced data demonstrating the long-term effectiveness of its Esprit BTK drug-eluting stent. The everolimus-eluting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback